BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ALR Technologies Inc. Announces New Board Members


9/4/2012 9:47:12 AM

RICHMOND, VA--(Marketwire - September 04, 2012) - ALR Technologies Inc. (OTCBB: ALRT) (the "Company"), a health information technology developer, is pleased to announce the appointment of Alfonso M. Salas, M.D. and Kenneth J. Robulak to its Board of Directors.

Dr. Salas has extensive experience across the medical industry, including consulting, managing clinical trials, disease management and preventative services. He served as the Medical Director in the office of the Ministry of Social Security and Labor in Colombia and managed the Occupational Health department. Additionally, Dr. Salas was a consultant for El Prado Medical Clinic and private medical offices which provided services to private medical insurances as well as to the Province of Magdalena, Colombia. Presently, he operates his own business consulting corporations on budgets, research and medical services.

Dr. Salas received his medical degree with distinction from Universidad Metroplitana of Barranquilla, Colombia.

Mr. Robulak earned a Bachelor of Commerce degree from the University of Calgary and F.I.C.B. (Fellow, Institute of Canadian Bankers) from the University of British Columbia. He worked in corporate and investment banking for 30 years and more recently worked as a consultant in the manufacturing industry. Currently, Mr. Robulak assists a Mexico-based company with its marketing in the United States through its office in Dallas.

Concurrent with the addition of the new board members, the Company also announces the retirement of Jaroslav V. Tichy, PhD, as Vice President of Technology and board member at ALR Technologies. Dr. Tichy will still serve as a consultant to the Company.

"We are very pleased with the additions of Dr. Salas and Mr. Robulak to our Board of Directors. Their deep knowledge in their respective industries of medical administration and finance will prove invaluable as we transition into a revenue-stage company," commented Sidney Chan, Chairman and Chief Executive Officer at ALR Technologies. "Dr. Tichy has been integral to the development of our company for many years. We wish him the best of luck in his retirement and thank him for his tireless commitment to bring our Health-e-Connect system and universal cable to fruition."

"It has been a primary goal of mine to see the Health-e-Connect system and universal cable reach commercialization before my retirement," said Dr. Tichy. "I am excited to assume a different role as a consultant to assist in the continued growth of the Company."

About ALR Technologies Inc.

ALRT Health-e-Connect System ("System") is the principal product of the Company. Heath-e-Connect is a web based patient management platform for medical professionals to improve compliance and adherence of care plans of patients in their homes. The System is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at http://www.alrt.com.

ALR Technologies: 804-554-3500 Ext. 704           e-mail: contact@alrt.com 

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.


ALR Technologies:
804-554-3500 Ext. 704
e-mail: contact@alrt.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES